Physicians on Sermo weighed in on triple agonist adoption. 34% want more data. 38% say…
Sermo HCP resources
Chronic Disease Management
Early-onset cancer rates are increasing: Here’s what physicians should know
Why are cancer rates rising in adults under 50? Explore the data, screening updates, and…
Next-generation sequencing (NGS) testing in clinical practice in 2026
NGS testing explained for physicians: Uses in oncology, liquid biopsies, and evolving reimbursement, with insights…
Journavx FDA approval: non-opioid pain management in 2026
Journavx (suzetrigine) is the first new pain drug class in 20 years. Explore trial results,…
The Lyme epidemic: is your practice ready for the global spread?
Analyze the current Lyme disease epidemic, focusing on tick habitat expansion, new Phase 3 vaccine…
How are ultra-processed foods impacting your patients’ health?
Analyze how ultra-processed foods drive chronic disease, strategies for clinical dietary screening, and evidence-based patient…
Opioid MDL accountability: prescribing risk and the CDC guidelines
Analyze how the Opioid MDL settlements and CDC guidelines are reshaping accountability and driving defensive…
GLP-1s: Who’s in control, doctors or PBMs?
Sermo’s new report explores the tension between GLP-1 efficacy and access. Discover how PBMs and…
The next generation of cardiovascular risk calculators
Physicians on Sermo share views on a new tool that could predict cardiovascular disease risk…
Understanding sound therapy: integrating auditory healing into practice
Sermo explores sound therapy's benefits and how it can help reduce anxiety and improve sleep…
Accurate blood test diagnoses Alzheimer’s disease
Discover how a simple blood test could detect Alzheimer’s early. Learn what this means for…
The impact of remote patient monitoring on digital health
Discover how the Sermo community uses remote patient monitoring to enhance healthcare with real-time data…